Douglas S Ingram Sarepta Therapeutics, Inc. (SRPT) insider trading activity

Douglas S Ingram is Chief Executive Officer of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 929,391 shares of SRPT, which is worth approximately $17.5 Million. The most recent transaction as insider was on Dec 07, 2025, when has been sold 539,084 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 929K

138.12% 3M change

138.12% 12M change

Total Value Held $17.5 Million

DOUGLAS S INGRAM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 07 2025	BUY Grant, award, or other acquisition	-	539,084 Added 36.71%	929,391 Common Stock
Nov 03 2023	BUY Open market or private purchase	$2,017,243 $79.97 p/Share	25,225 Added 6.07%	390,307 Common Stock
Nov 17 2021	BUY Open market or private purchase	$2,000,579 $79.94 p/Share	25,026 Added 6.42%	365,082 Common Stock
Jun 26 2021	SELL Payment of exercise price or tax liability	$1,432,085 $80.4 p/Share	17,812 Reduced 4.98%	340,056 Common Stock
Dec 31 2020	SELL Payment of exercise price or tax liability	$6,332,681 $170.49 p/Share	37,144 Reduced 9.4%	357,868 Common Stock

Also insider at

RLAY

Relay Therapeutics, Inc. Healthcare

ARWR

ARROWHEAD PHARMACEUTICALS, INC. Healthcare

Director

DSI

Douglas S Ingram

Chief Executive Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Value

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Sarepta Therapeutics, Inc.

Track Activities on SRPT

Account